X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4582) 4582
Publication (713) 713
Newsletter (98) 98
Book Review (42) 42
Book Chapter (5) 5
Magazine Article (3) 3
Conference Proceeding (2) 2
Book / eBook (1) 1
Dissertation (1) 1
Journal / eJournal (1) 1
Paper (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2603) 2603
pharmacology & pharmacy (2028) 2028
ofloxacin (1991) 1991
ofloxacin - pharmacology (1899) 1899
levofloxacin (1553) 1553
microbial sensitivity tests (1477) 1477
microbiology (1379) 1379
male (1264) 1264
female (1065) 1065
fluoroquinolones (1063) 1063
anti-bacterial agents - pharmacology (1048) 1048
ciprofloxacin (962) 962
anti-infective agents - pharmacology (959) 959
animals (870) 870
index medicus (833) 833
adult (789) 789
infectious diseases (739) 739
ofloxacin - therapeutic use (724) 724
ciprofloxacin - pharmacology (715) 715
middle aged (660) 660
ofloxacin - pharmacokinetics (569) 569
ofloxacin - administration & dosage (556) 556
aged (507) 507
quinolones (418) 418
drug resistance, microbial (413) 413
antibiotics (391) 391
pharmacokinetics (382) 382
anti-bacterial agents - therapeutic use (365) 365
research article (351) 351
anti-infective agents - therapeutic use (344) 344
fluoroquinolones - pharmacology (335) 335
bacterial infections and mycoses (325) 325
drug resistance, bacterial (321) 321
biochemical phenomena, metabolism, and nutrition (309) 309
mice (307) 307
susceptibility (300) 300
anti-infective agents - pharmacokinetics (291) 291
mycobacterium tuberculosis - drug effects (286) 286
adolescent (284) 284
streptococcus pneumoniae - drug effects (273) 273
resistance (265) 265
ofloxacin - adverse effects (264) 264
anti-bacterial agents - administration & dosage (262) 262
moxifloxacin (261) 261
administration, oral (257) 257
quinolones - pharmacology (256) 256
bacteria - drug effects (254) 254
mutation (239) 239
staphylococcus aureus - drug effects (238) 238
dose-response relationship, drug (237) 237
pseudomonas aeruginosa - drug effects (228) 228
rats (227) 227
bacteria (224) 224
time factors (222) 222
infections (221) 221
norfloxacin - pharmacology (216) 216
aged, 80 and over (215) 215
treatment outcome (212) 212
oxazines - pharmacology (210) 210
anti-infective agents - administration & dosage (208) 208
oncology (206) 206
quinolines - pharmacology (206) 206
in-vitro (200) 200
tuberculosis (199) 199
escherichia coli - drug effects (197) 197
anti-bacterial agents - pharmacokinetics (193) 193
fluoroquinolone (193) 193
norfloxacin (191) 191
analysis (188) 188
drug resistance (186) 186
antitubercular agents - pharmacology (177) 177
escherichia-coli (177) 177
research (177) 177
ofloxacin - chemistry (170) 170
naphthyridines - pharmacology (169) 169
ofloxacin - blood (169) 169
drugs (166) 166
gram-negative bacteria - drug effects (160) 160
drug interactions (159) 159
in vitro techniques (159) 159
drug therapy, combination (157) 157
anti-infective agents - adverse effects (155) 155
streptococcus-pneumoniae (155) 155
dna gyrase - genetics (154) 154
microbial sensitivity tests - methods (151) 151
drug resistance in microorganisms (149) 149
chromatography, high pressure liquid (148) 148
antimicrobial agents (146) 146
pharmacology (145) 145
rabbits (145) 145
bacterial infections - drug therapy (144) 144
gatifloxacin (144) 144
mutations (143) 143
dna gyrase (142) 142
heterocyclic compounds (142) 142
infection (140) 140
therapy (140) 140
area under curve (139) 139
aza compounds - pharmacology (137) 137
strains (137) 137
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4260) 4260
Japanese (153) 153
French (73) 73
Spanish (47) 47
Chinese (43) 43
Russian (39) 39
Turkish (22) 22
German (19) 19
Polish (9) 9
Italian (7) 7
Dutch (4) 4
Romanian (3) 3
Czech (2) 2
Danish (2) 2
Hungarian (2) 2
Korean (1) 1
Portuguese (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
PLoS Genetics, ISSN 1553-7390, 01/2013, Volume 9, Issue 1, pp. e1003144 - e1003144
High levels of antibiotic tolerance are a hallmark of bacterial biofilms. In contrast to well-characterized inherited antibiotic resistance, molecular... 
CELLS | BACTERIAL PERSISTENCE | PSEUDOMONAS-AERUGINOSA | ESCHERICHIA-COLI | GENETICS & HEREDITY | GENE-EXPRESSION | RESISTANCE | BETA-LACTAM ANTIBIOTICS | CYSTIC-FIBROSIS | INDUCTION | STRESS | Biofilms - drug effects | Plankton - drug effects | Starvation | Drug Tolerance - genetics | Biofilms - growth & development | Amino Acids - genetics | Ofloxacin - pharmacology | Mutagenesis | Escherichia coli - genetics | Fluoroquinolones - pharmacology | SOS Response (Genetics) | DNA Transposable Elements - genetics | Plankton - genetics | Anti-Bacterial Agents - pharmacology | Drug Resistance, Bacterial - drug effects | Escherichia coli - growth & development | Drug Resistance, Bacterial - genetics | Transposons | Antibiotics | Gene mutations | Physiological aspects | Genetic aspects | Dosage and administration | Research | Drug resistance | Health aspects | Biofilms | Microbiology | E coli | Bacteria | Mutation | Carbon | Index Medicus | Ofloxacin/pharmacology | DNA Transposable Elements/genetics | Bacterial/drug effects/genetics | Anti-Bacterial Agents/pharmacology | Plankton/drug effects/genetics | Escherichia coli/genetics/growth & development | Bacteriology | Fluoroquinolones/pharmacology | Life Sciences | Microbiology and Parasitology | Biofilms/drug effects/growth & development | Drug Tolerance/genetics | Amino Acids/genetics | Drug Resistance
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 07/2011, Volume 184, Issue 2, pp. 269 - 276
Journal Article
Diagnostic Microbiology & Infectious Disease, ISSN 0732-8893, 2013, Volume 76, Issue 2, pp. 187 - 196
Abstract In order to characterize molecular mechanisms of first- and second-line drug resistance in Mycobacterium tuberculosis and to evaluate the use of... 
Infectious Disease | Internal Medicine | Mutations | Pan-susceptible | MDR | Mycobacterium tuberculosis | XDR | ANTITUBERCULOSIS DRUGS | ETHAMBUTOL RESISTANCE | INFECTIOUS DISEASES | KANAMYCIN | EMBB GENE | CROSS-RESISTANCE | MICROBIOLOGY | ISONIAZID RESISTANCE | CAPREOMYCIN | STREPTOMYCIN RESISTANCE | 16S RIBOSOMAL-RNA | Isoniazid - pharmacology | Ethambutol - pharmacology | Humans | Genetic Loci | Antigens, Bacterial - genetics | Mycobacterium tuberculosis - drug effects | Capreomycin - pharmacology | Pyrazinamide - pharmacology | Ofloxacin - pharmacology | DNA-Directed RNA Polymerases | Tuberculosis, Multidrug-Resistant - microbiology | Polymerase Chain Reaction | Acetyltransferases | Republic of Korea | Amidohydrolases | Pentosyltransferases - genetics | Promoter Regions, Genetic | Mycobacterium tuberculosis - classification | DNA, Bacterial - isolation & purification | Streptomycin - pharmacology | Catalase - genetics | Oxidoreductases - genetics | Bacterial Proteins - genetics | Amikacin - pharmacology | DNA Primers | Kanamycin - pharmacology | Sequence Analysis, DNA | Mycobacterium tuberculosis - isolation & purification | DNA Gyrase - genetics | Fluoroquinolones - pharmacology | Mutation | Rifampin - pharmacology | Drug Resistance, Multiple, Bacterial - genetics | Mycobacterium tuberculosis - genetics | Tuberculosis, Multidrug-Resistant - drug therapy | Drug resistance in microorganisms | Antitubercular agents | Tuberculosis | Drug therapy | Genomics
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 03/2008, Volume 52, Issue 3, pp. 852 - 857
Journal Article
Microbial Pathogenesis, ISSN 0882-4010, 05/2017, Volume 106, pp. 50 - 59
The pervasive of bacterial resistance earnestly threaten the prevention and the treatment of infectious diseases. Therefore, scientific communities take... 
Essential oil | Antibiotics | Multi-drug-resistant bacteria | Synergism | CARVACROL | MICROBIOLOGY | IMMUNOLOGY | PITURANTHOS-CHLORANTHUS | ANTIBACTERIAL ACTIVITY | CHEMICAL-COMPOSITION | BIOLOGICAL-ACTIVITY | P-CYMENE | STAPHYLOCOCCUS-AUREUS | INHIBITORS | ANTIMICROBIAL ACTIVITY | EPIDEMIOLOGY | Plant Extracts - chemistry | Oils, Volatile - chemistry | Plant Extracts - pharmacology | Anti-Infective Agents - pharmacology | Cyclohexenes - chemistry | Escherichia coli - drug effects | Humans | Bacteria - drug effects | Oils, Volatile - pharmacology | Spleen - drug effects | Terpenes - chemistry | Cell Line - drug effects | Ofloxacin - pharmacology | Piperacillin - pharmacology | Novobiocin - pharmacology | Sesquiterpenes, Eudesmane - chemistry | Time Factors | Gas Chromatography-Mass Spectrometry - methods | Plant Oils - pharmacology | Cell Survival | Methicillin-Resistant Staphylococcus aureus - drug effects | Oxacillin - pharmacology | Tetracycline - pharmacology | beta-Lactamases - drug effects | Drug Synergism | Animals | Keratinocytes - drug effects | Amoxicillin - pharmacology | Monoterpenes - chemistry | Bacteria - pathogenicity | Cell Proliferation - drug effects | Mice | Acinetobacter baumannii - drug effects | Drug Resistance, Multiple, Bacterial - drug effects | Microbial Sensitivity Tests - methods | Plant Oils - chemistry | Drug Combinations | Drug resistance in microorganisms | Bacteria | Beta lactamases | Analysis
Journal Article
International Journal of Antimicrobial Agents, ISSN 0924-8579, 2005, Volume 26, Issue 6, pp. 463 - 472
This study was conducted to evaluate the relationship between antimicrobial resistance and antimicrobial use in a university hospital in Taiwan. Disk... 
Nosocomial infection | Antimicrobial resistance | Gram-negative bacteria | Taiwan | Antimicrobial use | ACQUIRED INFECTIONS | FLUOROQUINOLONE USE | INFECTIOUS DISEASES | STATES | AFFAIRS MEDICAL-CENTER | SUSCEPTIBILITY | INTENSIVE-CARE UNITS | ANTIBIOTIC-RESISTANCE | MICROBIOLOGY | antimicrobial use | antimicrobial resistance | PSEUDOMONAS-AERUGINOSA | MULTICENTER SURVEILLANCE | PHARMACOLOGY & PHARMACY | nosocomial infection | PATHOGENS | Levofloxacin | Humans | Ofloxacin - therapeutic use | Incidence | Cephalosporins - therapeutic use | Gram-Negative Bacterial Infections - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Ofloxacin - pharmacology | Carbapenems - pharmacology | Drug Resistance, Multiple, Bacterial | beta-Lactamase Inhibitors | Cephalosporins - pharmacology | Cross Infection - epidemiology | Length of Stay | Hospitals, University | beta-Lactamases - pharmacology | Fluoroquinolones - therapeutic use | Gram-Negative Bacterial Infections - drug therapy | beta-Lactamases - therapeutic use | Cross Infection - drug therapy | Gram-Negative Bacteria - drug effects | beta-Lactams - pharmacology | Carbapenems - therapeutic use | Cross Infection - microbiology | Fluoroquinolones - pharmacology | Taiwan - epidemiology | Gram-Negative Bacterial Infections - epidemiology | Anti-Bacterial Agents - pharmacology | Aminoglycosides - pharmacology | beta-Lactams - therapeutic use | Aminoglycosides - therapeutic use
Journal Article
Journal Article
Clinical & Experimental Allergy, ISSN 0954-7894, 01/2006, Volume 36, Issue 1, pp. 59 - 69
Summary Background Quinolones are widely used, broad spectrum antibiotics that can induce immediate- and delayed-type hypersensitivity reactions, presumably... 
quinolone | p–i concept | cross-reactivity | delayed hypersensitivity drug reaction | drug-reactive T cells | drug‐reactive T cells | cross‐reactivity | Delayed hypersensitivity drug reaction | p-i concept | Quinolone | Drug-reactive T cells | Cross-reactivity | RECOGNITION | SPECIFICITY | DRUG-SPECIFIC CD4(+) | OFLOXACIN | PROLIFERATION | SULFAMETHOXAZOLE | IMMUNOLOGY | LYMPHOCYTE-TRANSFORMATION TEST | CYTOKINE PROFILE | ALLERGY | CIPROFLOXACIN | CLONES | Fluoroquinolones - chemistry | Humans | Middle Aged | Aza Compounds - pharmacology | Norfloxacin - chemistry | Quinolones - pharmacology | Hypersensitivity, Delayed - immunology | Quinolines - pharmacology | Enoxacin - pharmacology | Ofloxacin - pharmacology | Quinolones - chemistry | Norfloxacin - pharmacology | Anti-Bacterial Agents - chemistry | Nalidixic Acid - chemistry | Nalidixic Acid - pharmacology | Aged, 80 and over | Adult | Female | Clone Cells | Patch Tests | Quinolines - chemistry | Cells, Cultured | Aza Compounds - chemistry | Ciprofloxacin - pharmacology | Pipemidic Acid - pharmacology | Antigen-Presenting Cells - immunology | Cross Reactions | Pipemidic Acid - chemistry | Drug Hypersensitivity - immunology | Fluoroquinolones - pharmacology | Ciprofloxacin - chemistry | Ofloxacin - chemistry | T-Lymphocytes - immunology | Aged | Anti-Bacterial Agents - pharmacology | Cell Proliferation - drug effects | Enoxacin - chemistry | Allergy | Allergic reaction | Analysis
Journal Article